2.2. Tinostamustine Increases the Expression of MICA and MICB, Ligands for the Activating NK Cell Receptor NKG2D, in Myeloma Cell Lines and Malignant Plasma Cells from Myeloma Patients. This evidence concerns the gene KLRK1 and plasma cell myeloma.